article thumbnail

Incorporating Redo-TAVR Feasibility Into Lifelong Aortic Valve Management

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e013571, November 1, 2023.

article thumbnail

CT Simulation for Redo-TAVR: Can We Predict Future Coronary Access?

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e013572, November 1, 2023.

TAVR 40
article thumbnail

Valve-in-Valve Transcatheter Aortic Valve Replacement Following 2 Surgical Aortic Valve Replacements

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e013305, November 1, 2023.

article thumbnail

Challenges and Future Directions in Redo Aortic Valve Reintervention After Transcatheter Aortic Valve Replacement Failure

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e012966, November 1, 2023. Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients.

article thumbnail

Temporal Changes in Procedural Success and Clinical Outcomes of MTEER by Mechanism of MR: Analysis of the STS/TVT Registry

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions, Volume 18, Issue 3 , Page e014819, March 1, 2025. Patients in shock were excluded. Patients were grouped by the mechanism of mitral regurgitation (MR) and divided into time periods.RESULTS:Overall, 68 028 patients were included.

article thumbnail

Transcatheter Palliation With Pulmonary Artery Flow Restrictors in Neonates With Congenital Heart Disease: Feasibility, Outcomes, and Comparison With a Historical Hybrid Stage 1 Cohort

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions, Ahead of Print. Cox regression was used to evaluate the association between palliation strategy and 6-month mortality.Results:From 2021 to 2023, 17 patients (median age, 4 days; interquartile range [IQR], 2–8; median weight, 2.5 kilograms [IQR, 2.1–3.3])

article thumbnail

Cardiac Reverse Remodeling and Changes in Heart Failure Indices After Transcatheter Tricuspid Valve Replacement in Adults With Congenital Heart Disease

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions, Ahead of Print. Background:There are limited data about changes in cardiac function (cardiac reverse remodeling) and heart failure indices after transcatheter tricuspid valve-in-valve replacement (TT-VIVR).